Sfoglia per AUTORE
CECCHI I
Collezione ASL Città di Torino

  

Items : 25

Biological therapies in thrombocytopenia and primary antiphospholipid syndrome: where are we now? in Expert opinion on biological therapy / Expert Opin Biol Ther. 2025 Mar 28. doi: 10.1080/14712598.2025.2484844.
2025
ASL Città di Torino

Radin M; Barinotti A; Galarza D; Cecchi I; Camerlo S; Vaccarino A; Roccatello D; Morotti A; Sciascia S;

2024
ASL Città di Torino

Sciascia S; Ferrara G; Roccatello L; Rubini E; Foddai SG; Radin M; Cecchi I; Rossi D; Barinotti A; Ricceri F; Gilcrease W; Baldovino S; Ferreira Poshar A; Conti A; Fenoglio R;

Pediatric Presentation of Antiphospholipid Syndrome: A Review of Recent Literature With Estimation of Local Prevalence. in Seminars in thrombosis and hemostasis / Semin Thromb Hemost. 2024 Mar;50(2):182-187. doi: 10.1055/s-0043-1764472. Epub 2023 Mar 20.
2024
ASL Città di Torino

Radin M; Cecchi I; Arbrile M; Montin D; Farinasso L; Cioffi M; Foddai SG; Barinotti A; Menegatti E; Baldovino S; Sciascia S; Roccatello D;

Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab. in Clinical kidney journal / Clin Kidney J. 2023 May 15;16(9):1465-1468. doi: 10.1093/ckj/sfad111. eCollection 2023 Sep.
2023
ASL Città di Torino

Sciascia S; Rilat MLA; Fenoglio R; Foddai SG; Radin M; Cecchi I; Cinnirella G; Crosasso P; Guidetti MG; Barinotti A; Baldovino S; Menegatti E; Roccatello D;

Open-label, prospective, phase II descriptive pilot trial of belimumab therapy for refractory and/or non-criteria manifestations of antiphospholipid syndrome: study protocol. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2023 Mar;41(3):597-604. doi: 10.55563/clinexprheumatol/qa2yb4. Epub 2022 Oct 28.
2023
ASL Città di Torino

Sciascia S; Radin M; Cecchi I; Barinotti A; Rubini E; Rossi D; Fenoglio R; Vaccarino A; Menegatti E; Roccatello D; Sciascia S; Radin M; Cecchi I; Barinotti A; Rubini E; Rossi D; Fenoglio R; Vaccarino A; Menegatti E; Roccatello D;

Reply to comment on: Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2023 Jan;41(1):197. doi: 10.55563/clinexprheumatol/g1a1u3. Epub 2022 Oct 13.
2023
ASL Città di Torino

Radin M; Rubini E; Cecchi I; Foddai SG; Barinotti A; Rossi D; Sciascia S; Roccatello D; Radin M; Rubini E; Cecchi I; Foddai SG; Barinotti A; Rossi D; Sciascia S; Roccatello D;

Daratumumab monotherapy for refractory lupus nephritis. in Nature medicine / Nat Med. 2023 Aug;29(8):2041-2047. doi: 10.1038/s41591-023-02479-1. Epub 2023 Aug 10.
2023
ASL Città di Torino

Roccatello D; Fenoglio R; Caniggia I; Kamgaing J; Naretto C; Cecchi I; Rubini E; Rossi D; De Simone E; Del Vecchio G; Cozzi M; Sciascia S;

2022
ASL Città di Torino

Sciascia S; Foddai SG; Alessandri C; Alunno A; Andreoli L; Barinotti A; Calligaro A; Canti V; Carubbi F; Cecchi I; Chighizola CB; Conti F; Emmi G; Fioravanti A; Fischetti F; Franceschini F; Gerosa M; Hoxha A; Larosa M; Lazzaroni MG; Nalli C; Pazzola G; Radin M; Raffeiner B; Ramoni VL; Rubini E; Sebastiani GD; Truglia S; Urban ML; et alii...

Erratum: Clinical Delphi on aPL Negativization: Report from the APS Study Group of the Italian Society for Rheumatology (SIR-APS). in Thrombosis and haemostasis / Thromb Haemost. 2022 Sep;122(9):e1. doi: 10.1055/s-0043-1769787. Epub 2023 May 24.
2022
ASL Città di Torino

Sciascia S; Foddai SG; Alessandri C; Alunno A; Andreoli L; Barinotti A; Calligaro A; Canti V; Carubbi F; Cecchi I; Chighizola CB; Conti F; Emmi G; Fioravanti A; Fischetti F; Franceschini F; Gerosa M; Hoxha A; Larosa M; Lazzaroni MG; Nalli C; Pazzola G; Radin M; Raffeiner B; Ramoni VL; Rubini E; Sebastiani GD; Truglia S; Urban ML; et alii...

Disease evolution in a long-term follow-up of 104 undifferentiated connective tissue disease patients. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2022 Mar;40(3):575-580. doi: 10.55563/clinexprheumatol/7vp1bo. Epub 2021 Jun 26.
2022
ASL Città di Torino

Foddai SG; Cecchi I; Rubini E; Radin M; Barinotti A; Rossi D; Sciascia S; Roccatello D;

Tailoring Tofacitinib Oral Therapy in Rheumatoid Arthritis: The TuTOR App. in International journal of environmental research and public health / Int J Environ Res Public Health. 2022 Apr 28;19(9):5379. doi: 10.3390/ijerph19095379.
2022
ASL Città di Torino

Radin M; Arbrile M; Cecchi I; Di Nunzio P; Buccarano N; Di Gregorio F; Milone V; Osella S; Crosasso P; Favuzzi MD; Barinotti A; Baldovino S; Menegatti E; Rossi D; Sciascia S; Roccatello D;

Circulating immune-complexes of IgG/IgM bound to B2-glycoprotein-I associated with complement consumption and thrombocytopenia in antiphospholipid syndrome. in Frontiers in immunology / Front Immunol. 2022 Sep 12;13:957201. doi: 10.3389/fimmu.2022.957201. eCollection 2022.
2022
ASL Città di Torino

Naranjo L; Stojanovich L; Djokovic A; Andreoli L; Tincani A; Ma?li?ska M; Sciascia S; Infantino M; Garcinuño S; Kostyra-Grabczak K; Manfredi M; Regola F; Stanisavljevic N; Milanovic M; Saponjski J; Roccatello D; Cecchi I; Radin M; Benucci M; Pleguezuelo D; Serrano M; Shoenfeld Y; Serrano A;

The global antiphospholipid syndrome score in women with systemic lupus erythematosus and adverse pregnancy outcomes. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2021 Sep-Oct;39(5):1071-1076. doi: 10.55563/clinexprheumatol/c96ief. Epub 2020 N
2021
ASL Città di Torino

Schreiber K; Radin M; Cecchi I; Rubini E; Roccatello D; Jacobsen S; Cuadrado MJ; Sciascia S;

Quality of life in patients with antiphospholipid antibodies differs according to antiphospholipid syndrome damage index (DIAPS). in European journal of internal medicine / Eur J Intern Med. 2021 Oct;92:134-136. doi: 10.1016/j.ejim.2021.07.004. Epub 2021 Jul 28.
2021
ASL Città di Torino

Radin M; Foddai SG; Cecchi I; Roccatello D; Sciascia S;

Clinical manifestations in patients with antiphospholipid antibodies: Beyond thrombosis and pregnancy loss. in Lupus / Lupus. 2021 May;30(6):884-892. doi: 10.1177/0961203321995248. Epub 2021 Feb 16.
2021
ASL Città di Torino

Cecchi I; Radin M; Rubini E; Foddai SG; Barinotti A; Roccatello D; Sciascia S;

Identifying phenotypes of patients with antiphospholipid antibodies: results from a cluster analysis in a large cohort of patients. in Rheumatology (Oxford, England) / Rheumatology (Oxford). 2021 Mar 2;60(3):1106-1113. doi: 10.1093/rheumatology/kez596.
2021
ASL Città di Torino
AO Ordine Mauriziano
AOU Città della Salute di Torino

Rossi D; Mengozzi G; Roccatello D; Bazzan M; Giachino O; Baldovino S; Vaccarino A; Cecchi I; Bertolaccini ML; Bertero MT; Rubini E; Radin M; Sciascia S;

Reducing the diagnostic delay in Antiphospholipid Syndrome over time: a real world observation. in Orphanet journal of rare diseases / Orphanet J Rare Dis. 2021 Jun 16;16(1):280. doi: 10.1186/s13023-021-01906-1.
2021
ASL Città di Torino

Radin M; Foddai SG; Barinotti A; Cecchi I; Rubini E; Sciascia S; Roccatello D;

2021
ASL Città di Torino

Radin M; Foddai S; Cecchi I; Rubini E; Barinotti A; Mahler M; Seaman A; Ramirez C; Casas S; Roccatello D; Sciascia S;

16th International congress on antiphospholipid antibodies task force report on clinical manifestations of antiphospholipid syndrome. in Lupus / Lupus. 2021 Jul;30(8):1314-1326. doi: 10.1177/09612033211020361. Epub 2021 May 27.
2021
ASL Città di Torino

Sciascia S; Radin M; Cecchi I; Levy RA; Erkan D;

Endothelial dysfunction and cardiovascular risk in lupus nephritis: New roles for old players? in European journal of clinical investigation / Eur J Clin Invest. 2021 Feb;51(2):e13441. doi: 10.1111/eci.13441. Epub 2020 Nov 15.
2021
ASL Città di Torino

Mancardi D; Arrigo E; Cozzi M; Cecchi I; Radin M; Fenoglio R; Roccatello D; Sciascia S;

2021
ASL Città di Torino

Radin M; Schreiber K; Cecchi I; Bortoluzzi A; Crisafulli F; de Freitas CM; Bacco B; Rubini E; Foddai SG; Padovan M; Gallo Cassarino S; Franceschini F; Andrade D; Benedetto C; Govoni M; Bertero T; Marozio L; Roccatello D; Andreoli L; Sciascia S;

Cerebrovascular events in patients with isolated anti-phosphatidyl-serine/prothrombin antibodies. in Immunologic research / Immunol Res. 2021 Aug;69(4):372-377. doi: 10.1007/s12026-021-09208-1. Epub 2021 Jul 10.
2021
ASL Città di Torino

Radin M; Barinotti A; Foddai SG; Cecchi I; Rubini E; Roccatello D; Menegatti E; Sciascia S;

Utilizing type I interferon expression in the identification of antiphospholipid syndrome subsets. in Expert review of clinical immunology / Expert Rev Clin Immunol. 2021 Apr;17(4):395-406. doi: 10.1080/1744666X.2021.1901581. Epub 2021 Mar 3
2021
ASL Città di Torino

Cecchi I; Radin M; Rodríguez-Carrio J; Tambralli A; Knight JS; Sciascia S;

Incidence of a First Thrombo-Embolic Event in Patients With Systemic Lupus Erythematosus and Anti-phosphatidylserine/prothrombin Antibodies: A Prospective Study. in Frontiers in medicine / Front Med (Lausanne). 2021 Feb 1;8:621590. doi: 10.3389/fmed.2021.621590. eCollection 2021.
2021
ASL Città di Torino

Sciascia S; Radin M; Cecchi I; Rubini E; Foddai SG; Barinotti A; Vaccarino A; Rossi D; Roccatello D;

Pilot prospective open, single-arm multicentre study on off-label use of tocilizumab in patients with severe COVID-19. in Clinical and experimental rheumatology / Clin Exp Rheumatol. 2020 May-Jun;38(3):529-532. Epub 2020 May 1.
2020
ASL Città di Torino

Sciascia S; Aprà F; Baffa A; Baldovino S; Boaro D; Boero R; Bonora S; Calcagno A; Cecchi I; Cinnirella G; Converso M; Cozzi M; Crosasso P; De Iaco F; Di Perri G; Eandi M; Fenoglio R; Giusti M; Imperiale D; Imperiale G; Livigni S; Manno E; Massara C; Milone V; Natale G; Navarra M; Oddone V; Osella S; Piccioni P; et alii...